Shandong Weigao Group Medical Polymer Co., Ltd.

Company Overview

Weigao Group was established in March 1988, the principal business of Weigao focus on medical devices and pharmaceuticals. In 2014 Weigao Group was listed in Growth Enterprise Market of the Stock Exchange of Hong Kong. In 2017, the revenue of Weigao is $6.4 billion. At present, Weigao has more than 26000 employees and 6.7 square KM medical product industrial park. Weigao produces more than 30 series, 400 categories and 60,000 specifications. Most of products has approved by CE and ISO. Some product also approved by FDA. Weigao has become one of the most reliable suppliers of medical system solution in the world. In addition, under the branding strategy, the Weigao products are exported to over 150 countries and areas.